Articles Referencing PBE

Biotechnology ETF Investing 101 - ETF News And Commentary

5/20/2013, 11:03 am from Zacks.com in Investing, ETFs

With ever-increasing health care spending and insatiable demand for new drugs, the biotechnology sector looks poised for good growth going forward. Furthermore, the U.S. biotech... Read >>

Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for May 14, 2013

5/13/2013, 7:39 am from NASDAQ.com News in News Headlines, Stocks

Amgen Inc. ( AMGN ) will begin trading ex-dividend on May 14, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on June 07, 2013. Shareholders who purchased AMGN stock... Read >>

Under The Hood: An Unheralded Biotech ETF

4/11/2013, 1:53 pm from Benzinga in Investing, ETFs, Investing Ideas

Another day, another set of fresh all-time highs for the major biotechnology ETFs . Biotech investors were treated to the same feat in late March , but as health care has continued to be a... Read >>

Gilead Puts Biotech ETFs in Focus - ETF News And Commentary

3/11/2013, 11:10 am from Zacks.com in Investing, ETFs

California-based Gilead Sciences ( GILD ) was in focus last week as it saw some encouraging clinical trial data on its HIV pill-TAF. This report pushed up GILD by about 4.5% last week and... Read >>

Amgen Inc. (AMGN) Ex-Dividend Date Scheduled for February 11, 2013

2/7/2013, 9:00 am from NASDAQ.com News in News Headlines, Stocks

Amgen Inc. ( AMGN ) will begin trading ex-dividend on February 11, 2013. A cash dividend payment of $0.47 per share is scheduled to be paid on March 07, 2013. Shareholders who purchased AMGN... Read >>

4 Health Care ETFs Your Broker Forgot to Mention

1/7/2013, 3:52 pm from Benzinga in Investing, ETFs, International, Investing Ideas

When it comes to health care ETFs , there are plenty for investors to choose from. How well acquainted folks are with all of their options in this sector is another story. Sure, it is safe to... Read >>

Arena Approval Boosts Biotech ETFs (ARNA, IBB, XBI)

6/27/2012, 2:41 pm from Benzinga in Investing, ETFs, Investing Ideas

News that the Food & Drug Administration has approved Arena Pharmaceuticals' (NASDAQ: ARNA ) weight-loss pill Lorcaserin is proving to be a boon for some biotech ETFs. Lorcaserin... Read >>

The Definitive Biotech ETF Guide (IBB, XBI, FBT)

5/21/2012, 1:35 pm from Benzinga in Investing, ETFs, Investing Ideas

Lifted by new drug approvals along with increased mergers and acquisitions activity and a churning rumor mill to that effect, biotechnology stocks have been stellar performers in 2012. ... Read >>

Re-Evaluating Your Healthcare Exposure: A Sector ETF Overview

3/4/2010, 2:45 pm from SeekingAlpha in Investing, ETFs, Stocks

Morningstar submits: By John Gabriel The health-care reform saga rolls on. Those hoping for clarity out of Washington following last week's bipartisan Healthcare Summit... Read >>